Cargando…
EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice
OBJECTIVE: In obesity, an increased macrophage infiltration in adipose tissue occurs, contributing to low-grade inflammation and insulin resistance. Epidermal growth factor receptor (EGFR) mediates both chemotaxis and proliferation in monocytes and macrophages. However, the role of EGFR inhibitors i...
Autores principales: | Prada, Patricia O., Ropelle, Eduardo R., Mourão, Rosa H., de Souza, Claudio T., Pauli, Jose R., Cintra, Dennys E., Schenka, André, Rocco, Silvana A., Rittner, Roberto, Franchini, Kleber G., Vassallo, José, Velloso, Lício A., Carvalheira, José B., Saad, Mario J.A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780887/ https://www.ncbi.nlm.nih.gov/pubmed/19696185 http://dx.doi.org/10.2337/db08-0506 |
Ejemplares similares
-
Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035)
Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice.
Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID:
19696185
por: Prada, Patricia O., et al.
Publicado: (2017) -
Expression of Concern. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves
Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes
2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185
por: Prada, Patricia O., et al.
Publicado: (2017) -
Central Exercise Action Increases the AMPK and mTOR Response to Leptin
por: Ropelle, Eduardo R., et al.
Publicado: (2008) -
Potent Cardioprotective Effect of the 4-Anilinoquinazoline Derivative PD153035: Involvement of Mitochondrial K(ATP) Channel Activation
por: Cavalheiro, Renata A., et al.
Publicado: (2010) -
Unsaturated Fatty Acids Revert Diet-Induced Hypothalamic Inflammation in Obesity
por: Cintra, Dennys E., et al.
Publicado: (2012)